These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6437668)
1. Biosynthesis of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Flesher JW; Myers SR; Blake JW Cancer Lett; 1984 Oct; 24(3):335-43. PubMed ID: 6437668 [TBL] [Abstract][Full Text] [Related]
2. Oxidative metabolism of 7-methylbenz[a]anthracene, 12-methylbenz[a]anthracene and 7,12-dimethylbenz[a]anthracene by rat liver cytosol. Flesher JW; Myers SR Cancer Lett; 1985 Feb; 26(1):83-8. PubMed ID: 3918789 [TBL] [Abstract][Full Text] [Related]
3. Bioalkylation of benz[a]anthracene, 7-methylbenz[a]anthracene, and 12-methylbenz[a]anthracene in rat lung cytosol preparations. Myers SR; Flesher JW Biochem Pharmacol; 1991 Jun; 41(11):1683-9. PubMed ID: 2043157 [TBL] [Abstract][Full Text] [Related]
4. 7-Sulfooxymethyl-12-methylbenz[a]anthracene is an electrophilic mutagen, but does not appear to play a role in carcinogenesis by 7,12-dimethylbenz[a]anthracene or 7-hydroxymethyl-12-methylbenz[a]anthracene. Surh YJ; Liem A; Miller EC; Miller JA Carcinogenesis; 1991 Feb; 12(2):339-47. PubMed ID: 1899811 [TBL] [Abstract][Full Text] [Related]
5. Mass spectrometric analysis of 7-sulfoxymethyl-12-methylbenz[a]anthracene and related electrophilic polycyclic aromatic hydrocarbon metabolites. Lehner AF; Horn J; Flesher JW J Mass Spectrom; 2004 Nov; 39(11):1366-78. PubMed ID: 15532073 [TBL] [Abstract][Full Text] [Related]
6. Oxidation of the trans-3,4-dihydrodiol metabolites of the potent carcinogen 7,12-dimethylbenz(a)anthracene and other benz(a)anthracene derivatives by 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase: effects of methyl substitution on velocity and stereochemical course of trans-dihydrodiol oxidation. Smithgall TE; Harvey RG; Penning TM Cancer Res; 1988 Mar; 48(5):1227-32. PubMed ID: 3124956 [TBL] [Abstract][Full Text] [Related]
7. Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice. DiGiovanni J; Diamond L; Singer JM; Daniel FB; Witiak DT; Slaga TJ Carcinogenesis; 1982; 3(6):651-5. PubMed ID: 6811143 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of benzo[a]pyrene and A-ring reduced 7,12-dimethyl benz[a]anthracene induced neoplastic transformation of human cells in vitro. Tejwani R; Witiak DT; Inbasekaran MN; Cazer FD; Milo GE Cancer Lett; 1981 Jul; 13(2):119-27. PubMed ID: 6796255 [TBL] [Abstract][Full Text] [Related]
9. 7, 12-dimethylbenz [a] anthracene-deoxyribonucleoside adduct formation in vivo: evidence for the formation and binding of a mono-hydroxymethyl-DMBA metabolite to rat liver DNA. Joyce NJ; Daniel FB Carcinogenesis; 1982; 3(3):297-301. PubMed ID: 6805976 [TBL] [Abstract][Full Text] [Related]
10. Benzo(e)pyrene-induced alterations in the metabolic activation of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene by hamster embryo cells. Baird WM; Salmon CP; Diamond L Cancer Res; 1984 Apr; 44(4):1445-52. PubMed ID: 6322978 [TBL] [Abstract][Full Text] [Related]
11. DNA adduct formation by 7,12-dimethylbenz[a]anthracene and its noncarcinogenic 2-fluoro analogue in female Sprague-Dawley rats. Daniel FB; Joyce NJ J Natl Cancer Inst; 1983 Jan; 70(1):111-8. PubMed ID: 6401826 [TBL] [Abstract][Full Text] [Related]
12. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Shou M; Korzekwa KR; Krausz KW; Buters JT; Grogan J; Goldfarb I; Hardwick JP; Gonzalez FJ; Gelboin HV Mol Carcinog; 1996 Dec; 17(4):241-9. PubMed ID: 8989918 [TBL] [Abstract][Full Text] [Related]
13. Sulfate esters of hydroxymethyl-methyl-benz[a]anthracenes as active metabolites of 7,12-dimethylbenz[a]anthracene. Watabe T; Ishizuka T; Fujieda T; Hiratsuka A; Ogura K Jpn J Cancer Res; 1985 Aug; 76(8):684-98. PubMed ID: 3930446 [TBL] [Abstract][Full Text] [Related]
14. Identification of phenols of 7,12-dimethylbenz[a]anthracene by conversion into their methyl ethers. Morreal CE; Clift RG J Chromatogr; 1985 Feb; 319(2):153-8. PubMed ID: 3920229 [TBL] [Abstract][Full Text] [Related]
15. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Cavalieri EL; Higginbotham S; RamaKrishna NV; Devanesan PD; Todorovic R; Rogan EG; Salmasi S Carcinogenesis; 1991 Oct; 12(10):1939-44. PubMed ID: 1934274 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of metabolic activation of 7,12-dimethylbenz(a)anthracene in vitro by aroclor 1254-induced rat liver S-9 fraction. Bigger CA; Tomaszewski JE; Andrews AW; Dipple A Cancer Res; 1980 Mar; 40(3):655-61. PubMed ID: 6781743 [TBL] [Abstract][Full Text] [Related]
17. A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[alpha]anthracene. Watabe T; Ishizuka T; Isobe M; Ozawa N Science; 1982 Jan; 215(4531):403-5. PubMed ID: 6800033 [TBL] [Abstract][Full Text] [Related]
19. Identification of 7,12-dimethylbenz[a]anthracene metabolites that lead to mutagenesis in mammalian cells. Huberman E; Chou MW; Yang SK Proc Natl Acad Sci U S A; 1979 Feb; 76(2):862-6. PubMed ID: 106395 [TBL] [Abstract][Full Text] [Related]
20. Comparative metabolism and DNA binding of 7,12-dimethylbenz[a]anthracene and its weakly carcinogenic 5-fluoro analog. Daniel FB; Cazer FD; D'Ambrosio SM; Hart RW; Kim WH; Witiak DT Cancer Lett; 1979 Apr; 6(4-5):263-72. PubMed ID: 108013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]